Tag: Prescription Drugs
Less Bleeding With Ticagrelor Alone in High-Risk Patients
Less bleeding with ticagrelor alone versus ticagrelor plus aspirin for patients after PCI
DPP4 Inhibitors Do Not Up Risk of Inflammatory Bowel Disease
Findings based on comparison to sulfonylureas, thiazolidinediones
Severe Adverse Cardiovascular Events Associated With Ibrutinib
Risk up for severe, sometimes fatal, events, including supraventricular arrhythmias, CNS events
Step-Up Strategy May Differ in Black Children With Asthma
Poorly controlled asthma in black children may respond to increased dose of inhaled glucocorticoid
Vedolizumab Beats Adalimumab for Ulcerative Colitis Remissions
But not for corticosteroid-free clinical remission; also, ustekinumab superior to placebo
More Blood Pressure Drugs Recalled
Some lots of losartan contaminated with the cancer-causing chemical N-methylnitrosobutyric acid
Dapagliflozin Lowers Risk for Worsening Heart Failure
Findings seen among patients with heart failure, reduced ejection fraction, irrespective of diabetes
SGLT2 Inhibitors Linked to Lower Risk for Heart Failure
Risk lower for HF, but not major CV events, compared with new users of DPP4 inhibitors
Racial/Ethnic Disparities Seen in PrEP Awareness, Discussions
Black and Hispanic men who have sex with men less likely to be aware, have discussed PrEP than whites
Linagliptin Noninferior for CV Risk in Early Type 2 Diabetes
Linagliptin compared with glimepiride for risk for major cardiovascular events in T2DM with elevated CV risk
